Skip to main content

Table 3 Postoperative maternal data

From: Role of tranexamic acid-soaked gelatin sponge in minimizing rectus sheath hematoma after cesarean section in women treated with warfarin, a simple tool for high-risk cases, a randomized controlled trial

 

Group 1

(n = 21)

Group 2

(n = 21)

Group 3

(n = 21)

P-value

Postoperative Hb

10.66 ± 1.13

10.5 (8.8–12.4)

9.77 ± 0.69

10 (8.4–11.2)

10.38 ± 0.94

10.2 (8.7–11.9)

0.01*

Postoperative HCT

31.87 ± 3.59

32.1 (26.2–37.6)

28.54 ± 1.85

28.9 (24.8–32.6)

30.34 ± 2.76

30.7 (26.1–35.4)

0.001*

EBL (ml)

442.19 ± 244.46

405 (164–1133)

744.38 ± 267.05

736 (174–1206)

664.29 ± 343.97

713 (100–1188)

0.004*

Intraperitoneal drain (ml)

121.43 ± 51.41

100 (50–200)

147.62 ± 67.96

150 (50–300)

166.67 ± 76.38

150 (50–300)

0.092

Sub rectus drain (ml)

190.48 ± 100.77

200 (50–450)

230.95 ± 107.79

200 (100–450)

307.14 ± 127.76

350 (100–500)

0.005*

Sub rectus discharge

 Serous

3 (14.29%)

2 (9.52%)

0 (0.00%)

0.085

 Sero-sanguineous

17 (80.95%)

16 (76.19%)

14 (66.67%)

 Bloody

1 (4.76%)

3 (14.29%)

7 (33.33%)

Postoperative hospital stay (days)

7.62 ± 0.97

8 (6–10)

7.62 ± 0.97

8 (6–10)

7.76 ± 1.04

8 (6–10)

0.867

Postoperative complication

 Rectus sheath hematoma

0 (0.00%)

0 (0.00%)

1 (4.76%)

362

 Wound infection

0 (0.00%)

0 (0.00%)

1 (4.76%)

362

 Thromboembolism

0 (0.00%)

0 (0.00%)

0 (0.00%)

NA

Need for re-operation

0 (0.00%)

0 (0.00%)

0 (0.00%)

NA

Need for blood transfusion

0 (0.00%)

0 (0.00%)

0 (0.00%)

NA

  1. *p-value is significant